Inactive Instrument

Pfizer Inc Stock price Nyse

Equities

Pharmaceuticals

End-of-day quote Nyse
- USD 0.00% Intraday chart for Pfizer Inc
Sales 2024 * 60.42B Sales 2025 * 63.09B Capitalization 157B
Net income 2024 * 7.89B Net income 2025 * 12.59B EV / Sales 2024 * 3.35 x
Net Debt 2024 * 45.61B Net Debt 2025 * 42.35B EV / Sales 2025 * 3.16 x
P/E ratio 2024 *
18.2 x
P/E ratio 2025 *
12.3 x
Employees -
Yield 2024 *
6.13%
Yield 2025 *
6.29%
Free-Float 58.92%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 62 92-12-31
Director of Finance/CFO 59 22-05-01
Chief Tech/Sci/R&D Officer - 19-06-30
Members of the board TitleAgeSince
Director/Board Member 66 20-03-31
Director/Board Member 64 17-02-22
Director/Board Member 60 13-09-26
More insiders
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Calendar
Related indices
More about the company
  1. Stock
  2. Equities
  3. Stock Pfizer, Inc.
  4. Stock Pfizer Inc - Nyse